CVS Health (CVS)
(Delayed Data from NYSE)
$57.40 USD
-0.28 (-0.49%)
Updated May 20, 2024 04:00 PM ET
After-Market: $57.36 -0.04 (-0.07%) 7:58 PM ET
5-Strong Sell of 5 5
A Value A Growth C Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$57.40 USD
-0.28 (-0.49%)
Updated May 20, 2024 04:00 PM ET
After-Market: $57.36 -0.04 (-0.07%) 7:58 PM ET
5-Strong Sell of 5 5
A Value A Growth C Momentum A VGM
Zacks News
Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.
Top Analyst Reports for PepsiCo, AbbVie & Honeywell
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including PepsiCo, Inc. (PEP), AbbVie Inc. (ABBV) and Honeywell International Inc. (HON).
CVS Health (CVS) Invests in Renewable Energy With New Pact
by Zacks Equity Research
CVS Health (CVS) to receive clean, renewable energy through a 12-year agreement with Constellation.
CVS Heath (CVS) MinuteClinic Earns 6th Health Care Approval
by Zacks Equity Research
CVS Heath's (CVS) MinuteClinic has an in-clinic Net Promotor Score of more than 81, putting it in the top customer rankings.
CVS Health (CVS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $71.75 in the latest trading session, marking a +0.38% move from the prior day.
CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Why Is CVS Health (CVS) Up 0.1% Since Last Earnings Report?
by Zacks Equity Research
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why You Should Retain CVS Health (CVS) Stock for Now
by Zacks Equity Research
Investors are optimistic about CVS Health (CVS) on continued growth across the entire range of insured and self-insured medical, pharmacy, dental and behavioral health products and services.
Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.
Should You Invest in the iShares U.S. Healthcare Providers ETF (IHF)?
by Zacks Equity Research
Sector ETF report for IHF
The Zacks Analyst Blog Highlights Alphabet, Raytheon, Blackstone, SAP SE and CVS Health
by Zacks Equity Research
Alphabet, Raytheon, Blackstone, SAP SE and CVS Health are included in this Analyst Blog.
Top Analyst Reports for Alphabet, Raytheon Technologies & Blackstone
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), Raytheon Technologies Corporation (RTX) and Blackstone Inc. (BX).
Insider Watch: 2 CEOs Buying Shares
by Derek Lewis
Insiders have a longer-term holding horizon than most, a critical aspect that market participants should know. Nonetheless, seeing an insider step in and buy is always reassuring.
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
CVS Health (CVS) Q1 Earnings Surpass Estimates, EPS View Cut
by Zacks Equity Research
CVS Health's (CVS) robust sales growth across all three operating segments drives top-line results.
CVS Health (CVS) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
The headline numbers for CVS Health (CVS) give insight into how the company performed in the quarter ended March 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Is CVS Health (CVS) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), CVS Health (CVS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
CVS Health (CVS) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
CVS Health (CVS) delivered earnings and revenue surprises of 6.28% and 4.50%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Herbalife Ltd (HLF) Misses Q1 Earnings Estimates
by Zacks Equity Research
Herbalife Ltd (HLF) delivered earnings and revenue surprises of -16.92% and 5.04%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Lamb Weston and TTEC Holdings have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Lamb Weston and TTEC Holdings have been highlighted as Zacks Bull and Bear of the Day.
CVS Health (CVS) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $72.26, marking a -0.84% move from the previous day.
CVS Health (CVS) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
CVS Health's (CVS) digital capabilities are expected to have driven consumer engagement across all CVS Health businesses in Q1.
Analysts Estimate CVS Health (CVS) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
CVS Health (CVS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks Industry Outlook Highlights CVS Health, Walgreens BootsAlliance, Rite Aid and Amazon
by Zacks Equity Research
CVS Health, Walgreens BootsAlliance, Rite Aid and Amazon have been highlighted in this Industry Outlook article.
3 Retail Pharmacy and Drugstore Stocks to Watch in a Growing Industry
by Urmimala Biswas
Zacks Retail Pharmacy and Drugstore industry players like CVS, WBA and RAD are likely to gain on the strength of their digital pharmacies.